Inclusion of appendices to clinical study reports in marketing authorisation applications

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/EWP/2998/03
Published23/06/2004
Effective from01/12/2004
KeywordsClinical study report, initial application dossier, study information, protocol, patient data listing, adverse event, case report form (CRF)
DescriptionThis document clarifies which appendices to clinical study reports should be systematically included in marketing authorisation applications and which may be available on request of the competent authorities.


Related content


How helpful is this page?

Average rating:

 Based on 1 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
1 ratings
    

Tell us more